Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 105,190	$ 104,713
Restricted cash	291	210
Short-term investments	189,902	216,137
Trade receivables	93,394	79,069
Inventory, net	6,873	8,087
Prepaid expenses and other current assets	14,327	13,752
Total current assets	409,977	421,968
Long-term inventory, net	25,097	23,187
Property and equipment, net	7,593	7,777
Long-term investments	20,548	20,323
Right of use assets	11,982	12,008
Other assets	4,850	5,157
Total assets	480,047	490,420
Current liabilities:
Accounts payable	10,049	11,644
Accrued expenses	92,635	113,292
Operating lease liabilities	1,071	937
Finance lease liabilities	1,795	1,835
Royalty financing obligations	34,305	32,676
Total current liabilities	139,855	160,384
Operating lease liabilities	7,779	7,924
Finance lease liabilities	2,314	2,124
Royalty financing obligations	466,613	481,053
Secured term loan	315,413	314,869
Total liabilities	931,974	966,354
Stockholders’ deficit:
Preferred stock, $0.01 par value; shares authorized - 5,000; no shares issued and outstanding at March 31, 2025 and December 31, 2024	0	0
Common stock, $0.01 par value; shares authorized - 450,000; shares issued and outstanding – 209,208 at March 31, 2025 and 208,543 at December 31, 2024	2,092	2,085
Additional paid-in capital	1,314,857	1,291,100
Accumulated other comprehensive income	1,132	921
Accumulated deficit	(1,770,008)	(1,770,040)
Total stockholders’ deficit	(451,927)	(475,934)
Total liabilities and stockholders’ deficit	$ 480,047	$ 490,420